Anna Greka

Anna Greka is an institute member of the Broad Institute of MIT and Harvard, where she leads a program aimed at dissecting fundamental mechanisms of disrupted cellular homeostasis in genetically defined kidney, metabolic, and degenerative diseases, with a special focus on membrane proteins.

Greka has been the recipient of several honors, including the Donald W. Seldin Young Investigator Award by the American Society of Nephrology and the American Heart Association, the Seldin-Smith Award for Pioneering Research from the American Society of Clinical Investigation (ASCI), and a Presidential Early Career Award for Scientists and Engineers (PECASE). She was also elected to the roles of ASCI Vice-President/President by her peers, and was selected as a member of the National Academy of Medicine’s Emerging Leaders Forum. Greka serves on the Harvard-MIT M.D.-Ph.D. Program Leadership Council and on the Board of Trustees of Anatolia College.

Greka holds an A.B. in biology from Harvard College, an M.D. from the Harvard-MIT program in Health Sciences and Technology (HST), and a Ph.D. in neurobiology from HMS.